The state agency that regulates and supervises medicines and pharmacies in Tajikistan. It is listed among the agencies of the health ministry.
The European Observatory's 2025 health system review names the Service for State Supervision of the Healthcare System and Social Protection of the Population as the state agency authorised to regulate and supervise pharmaceutical activities in Tajikistan, and says a Pharmacological Committee, part of the regulatory body, decides on the clinical evidence, safety and effectiveness of new medicines, doses and indications. The governing law, on medicines and pharmaceutical activities, was adopted in 2003 and last updated in 2022. The Ministry of Health and Social Protection's site lists the Service among its agencies, but its page there carried no text on 16 November 2026 and OnCo found no site of its own, so this record says nothing about how a cancer medicine is registered or a trial authorised. WHO's August 2026 list of regulators at maturity level 3 and 4 does not include it. The coordinates are an approximate Dushanbe city point, not the building.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/